Calabrese, Leonard H.
Molloy, Eamonn
Berger, Joseph
Article History
First Online: 14 October 2014
Competing interests
: L.H.C. has served as consultant to Genentech, GlaxoSmithKline and Pfizer in the area of progressive multifocal leukoencephalopathy (PML). E.M. has obtained research support from Roche, has served on advisory boards for Bristol-Myers Squibb, Pfizer and MSD, and received payment for developing educational materials relating to PML from GlaxoSmithKline. J.B. serves on the PML Adjudication Committees of Amgen, Astra Zeneca, Bristol-Myers Squibb, Eisai, Janssen, Millennium, Parexel, Pfizer, Roche and Takeda; he is a consultant to Genentech, Genzyme, Incyte, Inhibikase Therapeutics, Johnson & Johnson and Novartis. He has received grants from the PML Consortium, Biogen Idec and Novartis.